相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Elucidating Carfilzomib's Induced Cardiotoxicity in an In Vivo Model of Aging: Prophylactic Potential of Metformin
Panagiotis Efentakis et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Carfilzomib-induced endothelial dysfunction, recovery of proteasome activity, and prediction of cardiovascular complications: a prospective study
Efstathios Kastritis et al.
LEUKEMIA (2021)
Early predictors of left ventricular dysfunction in hypertensive patients: comparative cross-section study
Islam E. Shehata et al.
INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING (2020)
Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC)
Jelena Celutkiene et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Left Atrial Structure and Function, and Left Ventricular Diastolic Dysfunction JACC State-of-the-Art Review
Liza Thomas et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Cardiovascular Organ Damage and Blood Pressure Levels Predict Adverse Events in Multiple Myeloma Patients Undergoing Carfilzomib Therapy
Giulia Bruno et al.
CANCERS (2019)
Prospective Study of Cardiac Events During Proteasome Inhibitor Therapy for Relapsed Multiple Myeloma
Robert F. Cornell et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Molecular mechanisms of carfilzomib-induced cardiotoxicity in mice and the emerging cardioprotective role of metformin
Panagiotis Efentakis et al.
BLOOD (2019)
Left ventricular diastolic function as a possible predictor of severe carfilzomib-induced cardiovascular events
Yoshiaki Abe et al.
BLOOD ADVANCES (2019)
Irreversible proteasome inhibition with carfilzomib as first line therapy in patients with newly diagnosed multiple myeloma: Early in vivo cardiovascular effects
Mara Gavazzoni et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Age, Sex, and Blood Pressure-Related Influences on Reference Values of Left Atrial Deformation and Mechanics From a Large-Scale Asian Population
Jo-Nan Liao et al.
CIRCULATION-CARDIOVASCULAR IMAGING (2017)
Cardiac and renal complications of carfilzomib in patients with multiple myeloma
Meletios A. Dimopoulos et al.
BLOOD ADVANCES (2017)
New pharmacotherapy options for multiple myeloma
Roberto Mina et al.
EXPERT OPINION ON PHARMACOTHERAPY (2016)
Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study
Meletios A. Dimopoulos et al.
LANCET ONCOLOGY (2016)
Carfilzomib and the cardiorenal system in myeloma: an endothelial effect?
A. Rosenthal et al.
BLOOD CANCER JOURNAL (2016)
Tissue Tracking Technology for Assessing Cardiac Mechanics Principles, Normal Values, and Clinical Applications
Piet Claus et al.
JACC-CARDIOVASCULAR IMAGING (2015)
Cardiac complications in relapsed and refractory multiple myeloma patients treated with carfilzomib
S. Atrash et al.
BLOOD CANCER JOURNAL (2015)
Serial Echocardiographic Assessment of Patients (Pts) with Relapsed Multiple Myeloma (RMM) Receiving Carfilzomib and Dexamethasone (Kd) Vs Bortezomib and Dexamethasone (Vd): A Substudy of the Phase 3 Endeavor Trial (NCT01568866)
Stuart D. Russell et al.
BLOOD (2015)
Relationship between Left Ventricular Twist and Circulating Biomarkers of Collagen Turnover in Hypertensive Patients with Heart Failure
Nirvarthi Maharaj et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2014)
Primary proteasome inhibition results in cardiac dysfunction
Joerg Herrmann et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
Mechanisms of Disease Proteotoxicity and Cardiac Dysfunction - Alzheimer's Disease of the Heart?
Monte S. Willis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Ubiquitin Proteasome Dysfunction in Human Hypertrophic and Dilated Cardiomyopathies
Jaime M. Predmore et al.
CIRCULATION (2010)
Cardiac toxicity of high-dose chemotherapy
P Morandi et al.
BONE MARROW TRANSPLANTATION (2005)
Desmin-related cardiomyopathy in transgenic mice: A cardiac amyloidosis
A Sanbe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Myocytes die by multiple mechanisms in failing human hearts
S Kostin et al.
CIRCULATION RESEARCH (2003)